Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Psychiatry Research|May 18, 2010
Earliest functional declines in Huntington diseaseLeigh J Beglinger, Justin J F O'Rourke, Chiachi Wang, et al.Metabolism: Clinical and Experimental|September 11, 2012
Effect of low- and high-glycemic load on circulating incretins in a randomized clinical trialShauna S Runchey, Liisa M Valsta, Yvonne Schwarz, et al.The Journal of Nutrition|December 23, 2011
A low-glycemic load diet reduces serum C-reactive protein and modestly increases adiponectin in overweight and obese adultsMarian L Neuhouser, Yvonne Schwarz, Chiachi Wang, et al.Preventive Medicine|March 5, 2011
Effects of 12-month exercise on health-related quality of life: a randomized controlled trialIkuyo Imayama, Catherine M Alfano, Lisa A Cadmus Bertram, et al.The Journal of Neuropsychiatry and Clinical Neurosciences|May 14, 2010
"Frontal" behaviors before the diagnosis of Huntington's disease and their relationship to markers of disease progression: evidence of early lack of awarenessKevin Duff, Jane S Paulsen, Leigh J Beglinger, et al.Journal of Physical Activity & Health|October 6, 2012
Exercise adherence, cardiopulmonary fitness and anthropometric changes improve exercise self-efficacy and health-related quality of lifeIkuyo Imayama, Catherine M Alfano, Caitlin E Mason, et al.Neuropsychology|July 8, 2010
Self-paced timing detects and tracks change in prodromal Huntington diseaseKelly C Rowe, Jane S Paulsen, Douglas R Langbehn, et al.Movement Disorders : Official Journal of the Movement Disorder Society|July 13, 2010
Challenges assessing clinical endpoints in early Huntington diseaseJane S Paulsen, Chiachi Wang, Kevin Duff, et al.Preventive Medicine|July 18, 2013
Weight and metabolic effects of dietary weight loss and exercise interventions in postmenopausal antidepressant medication users and non-users: a randomized controlled trialIkuyo Imayama, Catherine M Alfano, Caitlin Mason, et al.Psychiatry Research|March 9, 2012
Patterns of serotonergic antidepressant usage in prodromal Huntington diseaseKelly C Rowe, Jane S Paulsen, Douglas R Langbehn, et al.Pageof 2